文献速递脑血管病认知障碍与痴呆

血管周围间隙与淀粉样蛋白、tau及血管生物标志物进展的关系

Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker Progression.
PubMed 文献 · Ann Neurol · 2026-07-17

该研究纳入Mayo老化研究与阿尔茨海默病研究中心共2229名处于老化-AD谱系参与者,用MRI量化血管周围间隙(PVS)与白质高信号(WMH),用PiB-PET和AV1451-PET测淀粉样蛋白与tau。结果显示基底节PVS与WMH体积及进展相关,与淀粉样蛋白的纵向关联仅见于淀粉样蛋白阴性者;半卵圆中心PVS与枕叶WMH相关。

要点

  • 基底节PVS负担较高者WMH负担更高且进展更快,可提示小血管病进展风险。
  • 基底节PVS与淀粉样蛋白的纵向轨迹关联仅见于淀粉样蛋白阴性个体。
  • 半卵圆中心PVS与枕叶WMH相关,支持其与脑淀粉样血管病早期改变有关。

核心结论

  • 基底节PVS可能是小血管功能障碍与WMH发病的早期指标,PVS与下游AD生物标志物进展的证据较弱。

研究设计与样本

  • 研究为纵向队列分析,纳入Mayo Clinic Study of Aging与Mayo ADRC共2229名老化-AD谱系参与者(平均年龄68.59±12.70岁,48.94%为女性)。
  • PVS与WMH用新型自研算法量化,淀粉样蛋白用[11C]PiB-PET、tau用AV1451-PET测量。
  • 横断面区域与全局关联用典型相关分析(CCA),纵向关联用年龄和性别校正的线性混合效应模型(含自然样条与受试者10折交叉验证)。

主要发现

  • 基底节PVS(PVS-BG)在横断面和纵向上均与更大的WMH体积相关。
  • PVS-BG在横断面上与更高的PiB标准化摄取值比(SUVR)相关,纵向轨迹关联仅限淀粉样蛋白阴性个体。
  • 半卵圆中心PVS(PVS-CSO)与淀粉样蛋白或tau无关,但与枕叶WMH相关,该模式为CAA特征。

临床怎么用

  • 可将基底节PVS负担作为识别小血管病进展高风险个体的影像学参考指标。
  • 对半卵圆中心PVS明显者应关注枕叶WMH,警惕脑淀粉样血管病早期改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Magnetic resonance imaging (MRI)-visible enlarged perivascular spaces (PVS) are markers of cerebral small vessel disease (SVD) and aging, processes implicated in both neurodegenerative and cerebrovascular pathologies. However, longitudinal positron emission tomography (PET) studies examining PVS as a mechanism underlying Alzheimer's disease (AD) pathophysiological progression are lacking. Our overall objective was to investigate the associations of baseline PVS burden with white matter hyperintensity (WMH) volume, amyloid-PET, and tau-PET, both cross-sectionally and longitudinally. METHODS: We examined 2,229 participants across the aging-AD spectrum from the Mayo Clinic Study of Aging (MCSA) and the Mayo Alzheimer's Disease Research Center (ADRC) (mean age = 68.59 ± 12.70 and 48.94% women). PVS and WMH were quantified using a novel in-house algorithm. Amyloid on [11C]Pittsburgh Compound B (PiB)-PET and tau on AV1451-PET were measured. Cross-sectional regional and global associations were examined using canonical correlation analysis (CCA). Longitudinal associations were examined using age- and sex-adjusted linear mixed effect (LME) models with natural splines and subject-wise 10-fold cross-validation. RESULT: Three distinct associations were observed: (1) PVS in the basal ganglia (PVS-BG) was associated with greater WMH volume both cross-sectionally and longitudinally; (2) PVS-BG covaried with higher PiB standardized uptake value ratio (SUVR) cross-sectionally, with longitudinal trajectory associations limited to amyloid-negative individuals; (3) PVS in the centrum semiovale (PVS-CSO) was not associated with amyloid or tau, but was associated with occipital WMH, a pattern characteristic of CAA. INTERPRETATION: Findings lend support for PVS-BG as an early indicator of small vessel dysfunction and WMH pathogenesis. Individuals with higher PVS-BG burden exhibited higher WMH burden and faster WMH progression, suggesting that PVS-BG may identify individuals at increased risk of progressive SVD. Evidence linking PVS to downstream AD biomarker progression was weaker. Findings support the relevance of PVS-CSO to CAA, suggesting that they may reflect changes occurring early in the disease process. ANN NEUROL 2026;100:695-708.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Low A, Gunter JL, Hu M, et al. Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker Progression. Ann Neurol. 2026. PMID: 42469606. doi:10.1002/ana.78299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。